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Background: Sturge-Weber syndrome is a congenital neurocutaneous disorder characterized by facial port-wine
stain, leptomeningeal angioma, and neurological disorders. Sturge-Weber syndrome can coexist with other
disorders in a few patients; however, muscular abnormalities have not been reported in patients with Sturge-Weber
syndrome.
Case presentation: A Chinese girl presented with extensive port-wine stains, congenital bilateral glaucoma, and
leptomeningeal angiomatosis. The neurocutaneous symptoms were consistent with the diagnostic criteria of
Sturge-Weber syndrome. Meanwhile, episodes of rhabdomyolysis were supported by the recurrent symptoms as
follows: exercise intolerance, hyperCKmia, elevated serum myoglobin, and renal failure. Myopathological features
and high level of blood long-chain acyl-carnitine indicated that episodes of rhabdomyolysis might be caused by
lipid metabolic myopathy. Causative mutations were not found in the CPT2, ACADVL, and GNAQ gene.
Conclusions: We report the first case that Sturge-Weber syndrome coexists with episodes of rhabdomyolysis
associated with lipid metabolic myopathy.
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Sturge-Weber syndrome (SWS), also known as encephalo-
facial angiomatosis, is a congenital neurocutaneous disorder
characterized by facial port-wine stains, leptomeningeal
angioma, oculopathy, and neurological problems including
seizures, stroke-like episodes, mental retardation, migraine,
and hemiparesis [1,2]. Somatic activating mutations in
guanine nucleotide-binding protein G(q) subunit alpha
(GNAQ) gene have been found to be associated with
Sturge-Weber syndrome [3]. The gene encodes a guanine
nucleotide protein that plays an important role in regulating
various cellular effectors. Mutant proteins disrupt vascular
development leading to the malformation of blood vessels
[3]. Sturge-Weber syndrome can coexist with hypomelano-
sis of Ito [4], polycystic kidney disease [5], and central
hypothyroidism in a few patients [6]; however, muscular
disorders have not been reported in patients with Sturge-
Weber syndrome. We describe a patient presenting with
extensive nevus flammeus, glaucoma, focal cerebral atrophy,
and episodes of rhabdomyolysis. It is the first case that* Correspondence: hongdaojun@hotmail.com
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A Chinese girl showed port-wine stains in bilateral faces,
neck, trunk and extremities at birth. She had not opened
eyes after birth, and then congenital bilateral glaucoma
was diagnosed. She began to walk at age 1, but she had
difficulty in running. She complained of muscle soreness
or myalgia in lower limbs after long walking or stair
climbing at age 2, but the symptoms can be relieved
after having a rest. At age 7, she suddenly had left limbs
weakness, accompanied by headache, nausea, vomiting,
and aphasia without disturbance of consciousness. The
symptoms were gradually relieved after 1 week. At age
10, a similar clinical episode happened again. At this
time when she was 14 years old, she complained of limb
myalgia, especially in both lower limbs after spring hiking.
On the next day, she presented with left hemiplegia and
headache. On the third day, she had aphasia and more
severe hemiplegia. Subsequently, her consciousness grad-
ually declined to somnolent state. The parent denied her. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 2 Radiological characteristics of brain. CT shows cortex
atrophy and gyral calcifications in right parietal lobe (A); coronal MRI
shows the right side of the cerebral cortex atrophy (B); enhanced MRI
reveals mild leptomeningeal angiomatosis in right temporal-parietal
areas (C); SWI shows vein hyperplasia in the atrophic cerebral sulcus (D).
Zhu et al. BMC Neurology 2013, 13:169 Page 2 of 4
http://www.biomedcentral.com/1471-2377/13/169history of suffering from epilepsy or taking antiepileptic
drugs.
On admission, she was in comatose state, accompanied
by episodes of twitching that began at left face, soon
spread to left limbs. She had extensive port-wine stains
distributing in both sides of her face, which also extended
to her neck, trunk, and limbs (Figure 1A, 1C). The right
eye was blind and exophthalmos (Figure 1B). The diameter
of left pupil was 2.5*3 mm owing to crystal implantation at
age 7. The left limbs had no response to pain stimulus.
Babinski’s sign was positive on the left side.
Blood test showed serum creatinine 504 umol/L (44–106
umol/L), urea nitrogen 51.4 mmol/L (2.3-7.8 mmol/L), uric
acid 1139 umol/L (150–440 umol/L), alanine aminotrans-
ferase 367 U/L (0–40 U/L), aspartate aminotransferase
670U/L (0–40 U/L), creatine kinase 44028 U/L (20–170
U/L), lactate dehydrogenase 1102 U/L (94–250 U/L),
myoglobin 241 ug/L (50–85 ug/L). Urinary occult blood
was strong positive (3+). Tandem mass spectrometry of
blood revealed myristoyl carnitine (C14-1) 0.35 umol/L
(0.02-0.25 umol/L), myristoyl-enoyl carnitine (C14:1–1)
0.83 umol/L, (0.012-0.3 umol/L), palmitoyl-enoyl carnitine
(C16:1–1) 0.32 umol/L (0.02-0.2 umol/L). Blood routine,
thyroid hormone and extractable nuclear antigen poly-
peptide spectrum were negative. Electroencephalogram
revealed persistent δ activities on the right hemisphere.
Cerebral CT showed focal atrophy of the right parietal lobe
with gyral calcifications (Figure 2A). Cranial MRI revealed
atrophy of cortex and other cerebral parenchyma in the
right hemisphere (Figure 2B). Enhanced MRI showed mild
leptomeningeal enhancement in right temporal-parietal
areas (Figure 2C). Vein hyperplasia in atrophic cerebral
sulcus was found on susceptibility weighted imaging (SWI)
(Figure 2D).
After obtaining the parental consent, muscle biopsy
revealed that some myofibers had numerous small round
vacuoles, and absence of muscle fiber necrosis and regen-
eration. These vacuoles were filled with lipid droplets onFigure 1 Patient’s pictures. Port-wine stains on bilateral faces,
trunk and limbs (A); right eye with buphthalmos and gray cornea
(B); port-wine stains in her hand (C).oil red O (ORO) stain (Figure 3A). Skin biopsy revealed that
the port-wine stains were constructed by many telangi-
ectasias under epidermis (Figure 3B). The analysis of
chromosome karyotype was normal. No mutation was
found in the carnitine palmitoyltransferase-II (CPT2),
very long-chain acyl-CoA dehydrogenase (ACADVL),
and GNAQ gene in blood and muscle samples.
The patient was given antiepileptic drugs (carbamazepine
200 mg, bid; and phenobarbitol sodium 100 mg, im, q8h),
multiple B vitamins and L-carnitine. The convulsion was
completely controlled on the 6th day after admission. Con-
sciousness was gradually improved and muscle strength of
left limbs reached 3/5 grade (MRC grade), but she still had
Broca’s aphasia. On the 6th day after admission, blood tests
showed serum creatine kinase 20570 U/L, creatinine 108
umol/L, and urea nitrogen 12.7 mmol/L. On the 50th day
after admission, port-wine stains were slightly faded and
narrowed; muscle strength of left limbs was 4+/5 grade;
aphasia was relieved; serum creatine kinase, urea nitrogen
and creatinine were back to level of normal references.
However, this girl experienced a similar clinical course
again at 7 months after discharge.
Discussion
Sturge-Weber syndrome is a rare congenital neurocuta-
neous disorder. The involved organs most often include
brain, skin, eyes, and bones, while other organs are rarely
Figure 3 Myopathological features. lipid droplets accumulating in some fibers on oil red O stain (A); skin biopsy reveals telangiectasias under
epidermis on hematoxylin & eosin stain (B).
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port-wine stains, congenital bilateral glaucoma, stroke-like
episodes, epilepsy, slight leptomeningeal angiomatosis, and
cortical atrophy with gyral calcifications in the right cere-
bral hemisphere. The symptoms as described above can
establish the diagnosis of Sturge-Weber syndrome [1,2].
Port-wine stains in patients with Sturge-Weber syndrome
often distribute in the facial areas innervated by the first
(V1) and second (V2) branches of trigeminal nerve, while
the third (V3) branch and contralateral face can also be
involved in some cases. In a few cases, the birthmark may
spread to neck, chest, and upper limbs [1,8,9]. In the
present case, port-wine stains were apparently extensive,
not only in bilateral faces, but also in neck, trunk, and
limbs. In addition, the leptomeningeal angioma was mild
on enhanced MRI and SWI images, while the cortex
atrophy of right hemisphere was apparent on MRI and
CT images. To our best knowledge, this clinical phenotype
is yet not to be reported in literatures [10].
On the other hand, the patient had extremely high
level of serum CK, accompanied by increased myoglobin
and acute renal failure. These symptoms indicated the
diagnosis of rhabdomyolysis [11]. Rhabdomyolysis is a con-
dition that damaged skeletal muscle fibers are broken down
rapidly, and then the brokendown products (such as myo-
globin) are released into blood. The muscle damage can
result from physical factors, metabolisms, medications,
infections, and hereditary disorders [11]. In this patient,
muscle metabolic disorders may be the possible cause of
rhabdomyolysis due to exercise intolerance and exercise-
related muscle soreness since her childhood. Significant
accumulation of lipid droplets in myofibers further sup-
ported that rhabdomyolysis may be related to lipid meta-
bolic myopathy. Finally, the increased level of long-chain
acyl-carnitine pointed to the possibility of carnitine palmi-
toyltransferase II deficiency [12] or very long chain acyl-
CoA dehydrogenasedeficiency [13]. However, genetic
analysis could not find causative mutations in the two genes.
Exertional rhabdomyolysis caused by steal phenomenon
of vascular malformation should be considered as the
differential diagnosis [14,15]. In the present case, thenumerous telangiectasias under epidermis (port-wine
stains) might perform as steal phenomenon causing the
muscle hypoperfusion that led to rhabdomyolysis. How-
ever, the results of myopathological changes and tandem
mass spectrometry were not consistent with ischemic
myopathy.
It has not been reported that the symptoms of Sturge-
Weber syndrome and episodes of rhabdomyolysis sim-
ultaneously appeared in one patient. Some patients with
Sturge-Weber syndrome can manifest as stroke-like epi-
sodes, which is easy to make a mistake with episodes of
rhabdomyolysis. Therefore, it is important to bear in mind
that Sturge-Weber syndrome can coexist with episodes of
rhabdomyolysis.
Somatic GNAQ mutation can moderately activate the
GPCR (G protein coupled receptors) downstream pathways
as revealed in SWS patients [3]. Somatic GNAQ mutation
can also result in blue nevi and melanocytic neoplasms of
the central nervous system [16,17]. If the somatic mutation
were to be presented in muscles, hyperactivation of the
GPCR pathways could alter or impair muscle metabolisms
that led to rhabdomyolysis. However, no GNAQ mutation
is found in the muscle tissue of this patient. It seems
that somatic GNAQ mutations are closely associated
with dermatologic diseases. Neurocutaneous disorders
usually involve germinal developmental abnormalities,
including central nervous system, musculoskeletal system,
eyes, and teeth [2]. Although muscular abnormalities have
not been described in Sturge-Weber syndrome or Klippel-
Trenaunay syndrome [18], both muscles and vessels are
simultaneously developed from mesoderm. The common
germinal origin lays the foundation for the possibility
of Sturge-Weber syndrome coexisting with episodes of
rhabdomyolysis. In addition, the rhabdomyolysis in this
case may be related to genetic anomalies of lipid metabol-
ism pathway. It is well known that gene mutations in
association with lipid metabolism pathway can result
in miscellaneous encephalopathy and ichthyosis [19].
Therefore, it is worthy to explore whether there is some
intrinsic relationship between Sturge-Weber syndrome
and episodes of rhabdomyolysis.
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We report the first case that Sturge-Weber syndrome co-
exists with episodes of rhabdomyolysis associated with lipid
metabolic myopathy. Although the intrinsic relationship
between Sturge-Weber syndrome and episodes of rhabdo-
myolysis is still unclear, the clinician should pay attention
to differentiate stroke-like episodes of Sturge-Weber
syndrome with episodes of rhabdomyolysis.
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